In both pediatric and adult thyroid tumors, we identified KEAP1 mutations with concurrent MAPK driver mutations, indicating potential cooperation between NRF2 and MAPK pathways in thyroid tumorigenesis. This evidence concerns the gene KEAP1 and thyroiditis.